Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hematologic Malignancy Biology Study

NCT00923442 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00923442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00923442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hematologic Malignancy Biology Study
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 24, 2004
Completion date
Not reported
Enrollment
550 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myelogenous leukemia, hodgkins lymphoma, myelodysplastic syndrome (mds), non-hodgkins lymphoma